LivaNova PLC
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $91.92
- 52-Week Range
- $53.37 – $99.38
- Market Cap
- $5.21B
- P/E (TTM)
- 27.09
- EPS (TTM)
- 3.49
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 3.80
- PEG Ratio
- 0.93
- Return on Equity
- 15.50%
- Return on Assets
- 5.11%
- Gross Margin
- 67.64%
- Operating Margin
- 14.30%
- Profit Margin
- 13.01%
- Current Ratio
- 1.46
- Debt/Equity
- 0.26
- Total Debt
- $357.07M
- Free Cash Flow
- $67.71M
- Revenue Growth
- 9.90%
- Earnings Growth
- -78.20%
- Enterprise Value
- $5.00B
Market Snapshot
About
LivaNova PLC is a global medical technology company focused on cardiovascular and neuromodulation solutions. The company develops and manufactures products for cardiac surgery, including heart-lung machines and oxygenators, as well as neuromodulation devices for epilepsy and treatment-resistant depression. LivaNova's product portfolio spans cardiac rhythm management, cardiac surgery, and advanced circulatory support technologies. The company serves healthcare providers worldwide with innovative medical devices and patient monitoring systems.